Characterization of in vitro activity and predictive biomarkers of the novel p21-activated kinase 4 (PAK4) inhibitor, PF-3758309, in colorectal cancer cell lines

被引：0
|
作者：
Kulikowski, Gillian N.
Pitts, Todd M.
Tan, Aik Choon
Tentler, John J.
Britt, Blair C.
Britt, Byron W.
Murray, Brion W.
Carley, William
Smeal, Tod
Guo, Chuangxing
Eckhardt, S. Gail
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2009年 / 8卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-09-B169
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B169
引用
收藏
页数：3
相关论文
共 50 条
  • [1] p21-Activated Kinase 4 (PAK4) as a Predictive Marker of Gemcitabine Sensitivity in Pancreatic Cancer Cell Lines
    Moon, Sung-Ung
    Kim, Jin Won
    Sung, Ji Hea
    Kang, Mi Hyun
    Kim, Se-Hyun
    Chang, Hyun
    Lee, Jeong-Ok
    Kim, Yu Jung
    Lee, Keun-Wook
    Kim, Jee Hyun
    Bang, Soo-Mee
    Lee, Jong Seok
    CANCER RESEARCH AND TREATMENT, 2015, 47 (03): : 501 - 508
  • [2] Identification of the p21-activated kinase inhibitor PF-3758309: A key effector of Ras signaling
    Murray, Brion
    CANCER RESEARCH, 2009, 69
  • [3] Inhibition of neuroblastoma proliferation by PF-3758309, a small-molecule inhibitor that targets p21-activated kinase 4
    Li, Zhiheng
    Li, Xiaolu
    Xu, Lixiao
    Tao, Yanfang
    Yang, Chun
    Chen, Xiaolan
    Fang, Fang
    Wu, Yi
    Ding, Xin
    Zhao, He
    Li, Mei
    Qian, Guanghui
    Xu, Yunyun
    Ren, Junli
    Du, Weiwei
    Wang, Jian
    Lu, Jun
    Hu, Shaoyan
    Pan, Jian
    ONCOLOGY REPORTS, 2017, 38 (05) : 2705 - 2716
  • [4] P21-activated kinase 4 (PAK4) as a predictive marker for gemcitabine in pancreatic cancer cell line
    Moon, Sung Ung
    Kim, Jin Won
    Sung, Ji Hea
    Kang, Mi Hyun
    Chang, Hyun
    Lee, Jeong Ok
    Kim, Yu Jung
    Lee, Keun Wook
    Kim, Jee Hyun
    Bang, Soo Mee
    Lee, Jong Seok
    CANCER RESEARCH, 2014, 74 (19)
  • [5] P21-Activated Kinase 4 (PAK4) Inhibitors as Potential Cancer Therapy
    Abdel-Magid, Ahmed F.
    ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (01): : 17 - 18
  • [6] Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth
    Murray, Brion W.
    Guo, Chuangxing
    Piraino, Joseph
    Westwick, John K.
    Zhang, Cathy
    Lamerdin, Jane
    Dagostino, Eleanor
    Knighton, Daniel
    Loi, Cho-Ming
    Zager, Michael
    Kraynov, Eugenia
    Popoff, Ian
    Christensen, James G.
    Martinez, Ricardo
    Kephart, Susan E.
    Marakovits, Joseph
    Karlicek, Shannon
    Bergqvist, Simon
    Smeal, Tod
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (20) : 9446 - 9451
  • [7] Association of the epithelial-to-mesenchymal transition phenotype with responsiveness to the p21-activated kinase inhibitor, PF-3758309, in colon cancer models
    Pitts, Todd M.
    Kulikowski, Gillian N.
    Tan, Aik-Choon
    Murray, Brion W.
    Aracaroli, John J.
    Tentler, John J.
    Spreafico, Anna
    Selby, Heather M.
    Kachaeva, Maria I.
    McPhillips, Kelly L.
    Britt, Blair C.
    Bradshaw-Pierce, Erica L.
    Messersmith, Wells A.
    Varella-Garcia, Marileila
    Eckhardt, S. Gail
    FRONTIERS IN PHARMACOLOGY, 2013, 4
  • [8] A novel role for p21-activated kinase 4 (PAK4) in endocrine resistance and disease progression
    Santiago-Gomez, A.
    Dragoni, I.
    NicAmhlaoibh, R.
    Trivier, E.
    Gee, J. M.
    Sims, A. H.
    Howell, S. J.
    Clarke, R. B.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S76 - S76
  • [9] Contribution of the epithelial-mesenchymal (EMT) phenotype to the sensitivity of colorectal cancer cell lines to the p21-activated kinase inhibitor, PF-3758309.
    Im, E.
    Pitts, T. M.
    Kulikowski, G.
    Tan, A.
    Tentler, J. J.
    Murray, B.
    Carley, W.
    Smeal, T.
    Guo, C.
    Eckhardt, S. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [10] Role for p21-activated kinase PAK4 in development of the mammalian heart
    Nekrasova, Tanya
    Minden, Audrey
    TRANSGENIC RESEARCH, 2012, 21 (04) : 797 - 811
12345